Chris Chapman, M.D.
President and Chief Medical Officer
Dr. Chris Chapman is the founder and CEO of Chapman Pharmaceutical Consulting Inc. He has extensive experience working with biotechnology companies to design clinical trial protocols and conduct clinical trials. He is an expert at helping clients meet or exceed quality and regulatory requirements.
Dr. Chapman received his M.D. degree from Georgetown University in Washington, D.C. in 1987. He completed his internship in Internal Medicine, a residency in Anesthesiology and a fellowship in Cardiovascular and Obstetric Anesthesiology at Georgetown. Since 1995, Dr. Chapman has been a critical care physician on the staff at Doctor’s Community Hospital in Lanham, Maryland. Dr. Chapman has served as Consultant Director of Regulatory and Medical Affairs for several biotechnology companies.
- Manager of Chapman Pharmaceutical Consulting Inc., a consulting organization that provides support on Product Safety, Pharmacovigilance, Medical Devices, Clinical, and Regulatory issues for pharmaceutical and biotech companies in North America, Europe, Japan, India and Africa.
- Physician monitor for ongoing clinical trials including both adult and pediatric subjects. Provides medical oversight on safety, analysis and reporting for FDA submission. Monitors the ongoing safety and integrates safety signals for Data Safety Monitoring Boards and clinical sites. Executes clinical development studies for COVID-19. Integrates medical and regulatory input from diverse sources and works effectively across multi-disciplinary work teams to manage the approval of pharmaceutical products.